| Short Description : | Recombinant-Hemagglutinin Influenza A-Indonesia-05-2005-H5N1-protein was developed from insect cells. For use in research applications. |
| Host: | Insect cells |
| Note: | STRICTLY FOR FURTHER RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
| Conjugation: | Unconjugated |
| Dilution Range: | Spin the vial and reconstite in distilled water to a concentration not less than 0.1 mg/mL. This can then be diluted into other buffers. |
| Formulation: | Lyophilised from PBS pH7.4, 5% trehalose, 5% mannitol. |
| Storage Instruction: | Can be stored in working aliquots at 2°C-8°C C for one month, or at-20°C C for six months, with a carrier protein without detectable loss of activity. Avoid repeated freeze/thaw cycles. NA |
| Immunogen: | Optimized DNA sequence encoding Influenza A Virus Hemagglutinin H5N1 subtype Indonesia 05-2005 strain (Asp17-Gln531) , was expressed in Insect cells. NA |
| Immunogen Region: | ASP17-GLN531 |
| Background | Recombinant InfluenzaH5N1 Hemaglutininis a monomer protein, and migrates due to glycosylation as an approximately 70 kDa protein under non-reducing conditions and as 45kDa and 25kDa fragments under reducing conditions in SDS-PAGE. |
Information sourced from Uniprot.org
